biomedcentral.com/bmcsurg/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
BMC Surgery
official impact factor 1.33
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My BMC Surgery

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore BMC Surgery

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Sections
  • Most viewed RSS
  • Archive
  • Supplements

Volume 9 (2009) - January 2009

next >
up
< previous

Research article   Open Access Highly Accessed

Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis

Jeffrey M East, Christopher SP Valentine, Emil Kanchev, Garfield O Blake BMC Surgery 2009, 9:2 (27 January 2009)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Methylene blue dye is an effective, affordable tumor mapping agent, which shortens the learning curve for surgeons to perform successful sentinel lymph node biopsies in breast cancer patients when assessed on an individual basis.

Study protocol   Open Access

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Andre Mihaljevic, Peter Büchler, Jan Harder, Ralf Hofheinz, Michael Gregor, Stephan Kanzler, Wolff Schmiegel, Volker Heinemann, Esther Endlicher, Günter Klöppel, Thomas Seufferlein, Michael Geissler BMC Surgery 2009, 9:1 (8 January 2009)

Abstract | Full text | PDF | PubMed


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.